OSR Holdings, Inc.
OSRHOSR Holdings is a global healthcare holding company that operates a hub-and-spoke business model to develop and commercialize a risk-diversified portfolio of pharmaceutical and medical device technologies.
Table of contents
Earnings
Next report
Sep 2, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
OSR Holdings is a global healthcare holding company that operates a hub-and-spoke business model to develop and commercialize a risk-diversified portfolio of pharmaceutical and medical device technologies. The company identifies and supports subsidiaries focused on innovative research in oral T-cell immunotherapies, recombinant biologics, and regenerative medicine for age-related degenerative diseases. Additionally, the company operates a medical device distribution platform in South Korea, which it is evolving into a fourth-party logistics (4PL) healthcare supply chain provider.
A differentiated global holding company utilizing a hub-and-spoke model to advance a risk-diversified portfolio of breakthrough therapeutic and regenerative technologies.
Questions, answered.
- What is OSR Holdings, Inc.'s market cap?
- OSR Holdings, Inc. (OSRH) has a market capitalization of $11.5M and trades on NASDAQ.
- Who are OSR Holdings, Inc.'s competitors?
- OSR Holdings, Inc.'s key competitors include Medtronic, AbbVie, Stryker, and others. These companies compete in similar markets and product categories.
- Who does OSR Holdings, Inc. partner with?
- OSR Holdings, Inc.'s notable partners include Richter-Helm BioLogics GmbH & Co. KG, Asahi Intecc, Microport Neurotech, and others.
- What subsidiaries does OSR Holdings, Inc. have?
- OSR Holdings, Inc.'s subsidiaries include Vaximm, Darnatein, RMC.
- Where is OSR Holdings, Inc. headquartered?
- OSR Holdings, Inc. is headquartered in United States of America. It has been publicly traded since 2025.